TARS earnings: a negative outcome, -5.9%

On March 14, 2022, Tarsus Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.9% in the window around the event. It had already run +28.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.